Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

Wall Street is drifting Thursday as gains for fashion brands and cigarette makers help offset drops for Ford Motor and Qualcomm following their latest profit reports. The S&P 500 was up 0.2% in ...

AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business ...

Amgen posted Q4 sales of $9.1 billion, up 11%, surpassing forecasts. EPS beat estimates, and analysts remain optimistic about growth prospects in 2025.

US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...

In corporate news, ATS Corp (TSX: ATS) reported third-quarter revenue above estimates. ATS shares popped $2.83, or 7.4%, to $41.02.Health-care shares soared 3%, driven by a jump of nine cents, or 6.2% ...

With the overall stock market very overbought, the four highest-yielding Dogs of the Dow look like outstanding ideas now.

They also usually inherit an "Established Brands" division ... Looking ahead, new biosimilar launches for Amgen's (AMGN) Prolia, and Roche's breast cancer drug Perjeta - both >$4bn per annum ...

On the economic data front, investors will focus on U.S. Initial Jobless Claims data, which is set to be released in a couple of hours. Economists expect this figure to be 214K, compared to last ...

Explore our top 10 DJIA stocks picks with expert analysis, market trends, and investment insights to help you make informed ...

Inc reported fourth-quarter earnings on Thursday that met analyst expectations, while revenue for the period matched consensus estimates. The fast-food restaurant operator, which owns KFC, Taco Bell, ...